Sequential re-rating: management describes the same offering landing bigger the second and third time around
The model's full reasoning — Q1 2018 call → NO我们根据提供的财报电话会议记录,判断管理层是否描述了“同类业务连续接单规模逐步扩大”的现象。需要寻找管理层明确对比当前与过去同类业务规模、且表明这种扩大是现实且持续、并处于早期阶段的表述。 在记录中,管理层提到: - 关于PBM业务,Jon Roberts说“we are more than halfway through our 2019 renewals”,但未提及单个合同规模增大。 - 关于零售业务,提到“partnerships with PBMs and health plans across the industry”,但未明确说单个合作规模变大。 - 关于Aetna交易,那是并购,不是同类业务接单。 - 关于MinuteClinic,提到“virtual care”等新服务,但未说单个项目规模增大。 - 关于长期护理业务,提到“challenges”,未说规模增大。 - 关于透析项目,是新产品,未提规模对比。 没有发现管理层明确说“现在的订单/合同/项目比过去更大”的表述。所有增长都归因于数量、市场份额、新客户等,而非单个业务单元规模扩大。因此答案应为NO。
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| ASO | Academy Sports and Outdoors, Inc. | Q1 2024 | 2024-06-11 | C+ |
| AKYA | Akoya Biosciences, Inc. | Q2 2023 | 2023-08-07 | C+ |
| SPT | Sprout Social, Inc. | Q2 2023 | 2023-08-04 | B+ |
| SGRY | Surgery Partners, Inc. | Q2 2022 | 2022-08-02 | B+ |
| CYBR | CyberArk Software Ltd. | Q3 2021 | 2021-11-04 | B+ |
| ASAN | Asana, Inc. | Q2 2022 | 2021-09-01 | B+ |
| OWL | Blue Owl Capital Inc. | Q2 2021 | 2021-08-10 | B+ |
AKYA · Q2 2023 → YESThe question is: Does management describe that the company's SUCCESSIVE ENGAGEMENTS OF THE SAME KIND ARE COMING IN AT PROGRESSIVELY LARGER SIZE? YES The transcript shows management describing a clear pattern of escalating project sizes in the translational/clinical space. Brian notes a migration from exploratory studies (reasonable size) to larger retrospective studies and even larger retrospective-prospective ongoing clinical studies, with projects moving "further and further downstream.
ASAN · Q2 2022 → YESThe question is: Does management describe that the company's SUCCESSIVE ENGAGEMENTS OF THE SAME KIND ARE COMING IN AT PROGRESSIVELY LARGER SIZE? YES Management describes exactly this pattern. Dustin notes the company is “closing larger deals and expanding seats across departments and geographies quickly in large organizations,” and that the growth in the >$50k cohort “reflected an acceleration in our largest enterprise customers.
SGRY · Q2 2022 → YESThe question is: Does management describe that the company's SUCCESSIVE ENGAGEMENTS OF THE SAME KIND ARE COMING IN AT PROGRESSIVELY LARGER SIZE? YES The transcript shows management describing exactly this pattern for physician recruiting cohorts. Wayne notes that the 2022 cohorts are “no exception to this trend, bringing more cases with a higher overall net revenue per case than our 2021 cohorts did in the same period last year.